Prabhakaran Shyam, Fonarow Gregg C, Smith Eric E, Liang Li, Xian Ying, Neely Megan, Peterson Eric D, Schwamm Lee H
*Department of Neurology, Northwestern University, Chicago, Illinois; ‡Ahmanson-UCLA Cardiomyopathy Center, Los Angeles, California; §Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada; ¶Duke Clinical Research Institute, Durham, North Carolina; and ‖Division of Neurology, Massachusetts General Hospital, Boston, Massachusetts.
Neurosurgery. 2014 Nov;75(5):500-8. doi: 10.1227/NEU.0000000000000475.
Prior studies have suggested that hospital case volume may be associated with improved outcomes after subarachnoid hemorrhage (SAH), but contemporary national data are limited.
To assess the association between hospital case volume for SAH and in-hospital mortality.
Using the Get With The Guidelines-Stroke registry, we analyzed patients with a discharge diagnosis of SAH between April 2003 and March 2012. We assessed the association of annual SAH case volume with in-hospital mortality by using multivariable logistic regression adjusting for relevant patient, hospital, and geographic characteristics.
Among 31,973 patients with SAH from 685 hospitals, the median annual case volume per hospital was 8.5 (25th-75th percentile, 6.7-12.9) patients. Mean in-hospital mortality was 25.7%, but was lower with increasing annual SAH volume: 29.5% in quartile 1 (range, 4-6.6), 27.0% in quartile 2 (range, 6.7-8.5), 24.1% in quartile 3 (range, 8.5-12.7), and 22.1% in quartile 4 (range, 12.9-94.5). Adjusting for patient and hospital characteristics, hospital SAH volume was independently associated with in-hospital mortality (adjusted odds ratio 0.79 for quartile 4 vs 1, 95% confidence interval, 0.67-0.92). The quartile of SAH volume also was associated with length of stay but not with discharge home or independent ambulatory status.
In a large nationwide registry, we observed that patients treated at hospitals with higher volumes of SAH patients have lower in-hospital mortality, independent of patient and hospital characteristics. Our data suggest that experienced centers may provide more optimized care for SAH patients.
先前的研究表明,医院的病例数量可能与蛛网膜下腔出血(SAH)后的预后改善相关,但当代全国性数据有限。
评估SAH的医院病例数量与院内死亡率之间的关联。
利用“遵循指南-卒中”注册库,我们分析了2003年4月至2012年3月期间出院诊断为SAH的患者。我们通过多变量逻辑回归评估年度SAH病例数量与院内死亡率的关联,并对相关的患者、医院和地理特征进行了调整。
在来自685家医院的31973例SAH患者中,每家医院每年的病例数量中位数为8.5例(第25-75百分位数,6.7-12.9例)。平均院内死亡率为25.7%,但随着年度SAH病例数量的增加而降低:第1四分位数(范围4-6.6例)为29.5%,第2四分位数(范围6.7-8.5例)为27.0%,第3四分位数(范围8.5-12.7例)为24.1%,第4四分位数(范围12.9-94.5例)为22.1%。对患者和医院特征进行调整后,医院SAH病例数量与院内死亡率独立相关(第4四分位数与第1四分位数相比,调整后的优势比为0.79,95%置信区间为0.67-0.92)。SAH病例数量的四分位数也与住院时间相关,但与出院回家或独立行走状态无关。
在一个大型全国性注册库中,我们观察到在SAH患者数量较多的医院接受治疗的患者院内死亡率较低,且与患者和医院特征无关。我们的数据表明,经验丰富的中心可能为SAH患者提供更优化的治疗。